Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study

被引：4

作者：

Iacovelli, R. ^{[1
]}

Ciccarese, C. ^{[1
]}

Bersanelli, M. ^{[2
]}

Zucali, P. A. ^{[3
]}

Fantinel, E. ^{[4
]}

Bimbatti, D. ^{[5
]}

Verzoni, E. ^{[6
]}

Accettura, C. ^{[7
]}

Bonomi, L. ^{[8
]}

Buttigliero, C. ^{[9
]}

Fornarini, G. ^{[10
]}

Pipitone, S. ^{[11
]}

Atzori, F. ^{[12
]}

Masini, C. ^{[13
]}

Massari, F. ^{[14
]}

Primi, F. ^{[15
]}

Buti, S. ^{[16
]}

Perrino, M. R. A. ^{[17
]}

Pafumi, S. ^{[18
]}

Tortora, G. ^{[1
]}

机构：

[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Med Oncol, Rome, Italy

[2] Univ Hosp Parma, Dipartimento Oncol Med, Parma, PR, Italy

[3] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy

[4] AOU Integrata Verona, UOC Oncol Dept, Osped Borgo Trento, Verona, Italy

[5] IOV Ist Oncol Veneto IRCCS, Med Oncol Dept 1, Padua, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[7] Osped Vito Fazzi ASL Lecce, Med Oncol, Lecce, Italy

[8] ASST Papa Giovanni XXIII, Oncol Dept, Bergamo, Italy

[9] Azienda Osped Univ San Luigi Gonzaga, Med Oncol, Orbassano, Italy

[10] IRCCS Osped Policlin San Martino, Hematol & Oncol Dept, Genoa, Italy

[11] Azienda Osped Univ Policlin Modena, Dipartimento Oncol Med, Modena, Italy

[12] Azienda Osped Univ Cagliari, Med Oncol, Monserrato, Italy

[13] Azienda Osped Arcispedale Santa Maria Nuova IRCCS, Oncol Unit, Reggio Emilia, Italy

[14] AOU Policlin S Orsola Malpighi, Oncol Med Padiglione 2, Bologna, Italy

[15] Osped Belcolle ASL Viterbo, Med Oncol, Viterbo, Italy

[16] Univ Parma, Dept Med & Surg, Parma, Italy

[17] IRCCS Humanitas Res Hosp, Dept Oncol, Rozzano, Italy

[18] AOU Integrata Verona Univ Verona, Oncol Dept, Verona, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1884MO

引用

页码：S1013 / S1013

页数：1